Singh Shawn (CIK 1412071) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy VTGN (36,818 shares), Buy VTGN (7,541 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Vistagen Therapeutics, Inc. (VTGN) | President and CEO | Buy | 36,818 | $7,073 |
| 2025-07-01 | Vistagen Therapeutics, Inc. (VTGN) | President and CEO | Buy | 7,541 | $12,820 |
Source: SEC Form 4 filings · as of 2026-07-02